News | Pharmaceuticals

Statins are associated with improved heart structure and function, according to research presented at EuroCMR 2017, May 25-27 in Prague. The research team reported the benefits were above and beyond the cholesterol lowering effect of statins.

Home May 26, 2017
Home
News | Heart Failure

Recent outcomes from the MAVERIC clinical trial confirm earlier positive findings that MVRx’s Arto System safely and effectively treats mitral valve regurgitation associated with congestive heart failure. The results, presented by leading cardiologists at EuroPCR 2017, May 16-19 in Paris, France, offer heart patients the promise of a less-invasive treatment for a life-threatening problem that affects more than 5 million people worldwide.

Home May 26, 2017
Home
Videos | Cardiovascular Ultrasound

This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative ...

Home May 26, 2017
Home
Videos | Cardiovascular Ultrasound

This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Strain Fundamentals ...

Home May 26, 2017
Home
News | Enterprise Imaging

At the 2017 annual meeting of the Society for Imaging Informatics in Medicine (SIIM), June 1-3 in Pittsburgh, Konica Minolta Healthcare Americas Inc. will showcase advanced specialty viewing capabilities of the Exa Enterprise Imaging platform. The platform facilitates the viewing of large medical imaging files, such as cardiac imaging and nuclear medicine, quickly and efficiently on existing workstations throughout the enterprise. With the Exa diagnostic quality Zero Footprint Universal Viewer, clinicians can view these images and more from any modality and any vendor. Exa delivers relevant priors from the picture archiving and communication system (PACS) or vendor neutral archive (VNA), including cardiovascular images, quickly and securely.

Home May 25, 2017
Home
Videos | Leads Implantable Devices

Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancements ...

Home May 25, 2017
Home
News | Cardiovascular Surgery

A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day reduction in ICU stay and a $3,654 reduction in per-patient hospitalization costs for coronary artery bypass graft (CABG) surgery. The reported outcomes, which included no severe hypoglycemia less than 40 mg/dL, were derived from an intensive glycemic control protocol supported by Glytec’s Glucommander for personalized insulin dosing.

Home May 25, 2017
Home
FDA says gadolinium retention in the brain is not a safety issue
Feature | Magnetic Resonance Imaging (MRI)

May 25, 2017 — A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast ...

Home May 25, 2017
Home
The Boston Scientific Lotus TAVR Valve
Feature | Heart Valve Technology

May 25, 2017 — Positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program ...

Home May 25, 2017
Home
News

The May/June digital edition of Diagnostic and Interventional Cardiology (DAIC) is now available at http:/ ...

Home May 25, 2017
Home
News | Interventional Radiology

Fourteen members of the Society of Interventional Radiology (SIR) took to Capitol Hill recently to express the society’s support for a bill that would expand access to government-funded graduate medical education (GME) opportunities to newly recognized primary specialties, including interventional radiology.

Home May 24, 2017
Home
News | Heart Valve Technology

May 24, 2017 — Late-breaking data presented at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter ...

Home May 24, 2017
Home
News

May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of ...

Home May 24, 2017
Home
News

W. L. Gore & Associates (Gore) announced positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech Republic. Gore plans to submit the positive data to the U.S. Food and Drug Administration (FDA) to seek a PFO indication for the Gore Cardioform Septal Occluder by year-end 2017.

Home May 24, 2017
Home
News | Cardiovascular Ultrasound

May 24, 2017 — Philips recently announced the results from a global study indicating that automated three-dimensional ...

Home May 24, 2017
Home
Subscribe Now